DermaWill
ActiveSummary
DermaWill has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €153,398 and a net result of €81,695. Its solvency ranks better than 52% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
What the company does
- Name clauseThe name the company operates under according to its articles.
- DermaWill
- Legal form clauseThe legal form, such as BV, NV or CV, which decides which company-law rules apply.
- One provision in the deed
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région Bruxelles Capitale, transfert porté à la connaissance du Conseil Provincial de l’Ordre des Médecins compétent,conformément aux règles…” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Un ou plusieurs administrateurs, en cas de vacance par décès,démission ou autre cause,administrateurs restants peuvent pourvoir…” (deed in French)
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Nominatives, ne peuvent être données en garantie” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Fourth Thursday of June at 18:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- One provision in the deed
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Pouvoirs émoluments mode liquidation, nomination met fin pouvoirs organe” (deed in French)